Pharmaceutical Industry Information Portal


All posts by tag


Takeda Pharmaceutical expected fourth-quarter net income to decline

Takeda is expected to post a 92% drop in net profit from a year earlier to 15.96 billion yen ($122.3 million) for the quarter...

Engitix and Takeda expand collaboration in antifibrotic therapy

Engitix Ltd., a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, April...

Takeda and Resilience enter development deal for plasma meds

The Takeda Pharmaceutical Co-led group that is developing a blood plasma treatment for COVID-19 has started manufacturing while the late-stage trial to determine whether...

Expert Articles